Delivery Order SPE2DR25D2014-SPE2DR26FA1V6
Award Date 1/8/26
Potential Completion Date 1/9/26
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,611.49 delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, an immunosuppressant medication commonly prescribed to prevent organ rejection in transplant patients and treat certain autoimmune conditions. The contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a firm fixed price delivery order with no set-aside designation. The award was executed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, a pharmaceutical product used primarily for immunosuppression in transplant patients and certain autoimmune conditions. This competitively awarded, non-set-aside contract has a ceiling value of $9,624.81 with a firm fixed price structure and an ultimate completion date of October 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken,...
- On January 6, 2026, the Defense Logistics Agency awarded a $25,031.72 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for 100 tablets of CellCept 500 mg, an immunosuppressant medication commonly used in transplant and autoimmune disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.50 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication used to prevent organ...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count packages) valued at $7,746.68 under a firm fixed-price contract. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500-count units) valued at $44,285.82 with a firm fixed price structure. The delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive award with no set-aside designation. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for CellCept 500 mg tablets (100 count) valued at $1,283.84, with an award date of August 13, 2025, and ultimate completion by August 14, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a $31,747.33 delivery order to AmerisourceBergen Drug Corp for 100-count bottles of CellCept 500 mg tablets, a pharmaceutical product used primarily for immunosuppression in transplant patients and autoimmune conditions. The contract, issued on June 2, 2025, carries a firm fixed price structure with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. Performance will be executed at the vendor's corporate office...